B

Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613

Watchlist Manager
Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
Watchlist
Price: 8.05 HKD 0.63%
Market Cap: 6.7B HKD
Have any thoughts about
Beijing Tong Ren Tang Chinese Medicine Co Ltd?
Write Note

Beijing Tong Ren Tang Chinese Medicine Co Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Beijing Tong Ren Tang Chinese Medicine Co Ltd
Total Equity Peer Comparison

Comparables:
G
512
U
3933
1177
C
3320
H
13

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
B
Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
Total Equity
HK$3.8B
CAGR 3-Years
7%
CAGR 5-Years
4%
CAGR 10-Years
11%
G
Grand Pharmaceutical Group Ltd
HKEX:512
Total Equity
HK$15.7B
CAGR 3-Years
9%
CAGR 5-Years
15%
CAGR 10-Years
33%
U
United Laboratories International Holdings Ltd
HKEX:3933
Total Equity
ÂĄ13.5B
CAGR 3-Years
14%
CAGR 5-Years
16%
CAGR 10-Years
9%
Sino Biopharmaceutical Ltd
HKEX:1177
Total Equity
ÂĄ32.8B
CAGR 3-Years
10%
CAGR 5-Years
2%
CAGR 10-Years
22%
C
China Resources Pharmaceutical Group Ltd
HKEX:3320
Total Equity
HK$48.4B
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
N/A
H
HUTCHMED (China) Ltd
HKEX:13
Total Equity
$740.1m
CAGR 3-Years
-9%
CAGR 5-Years
16%
CAGR 10-Years
23%

See Also

What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's Total Equity?
Total Equity
3.8B HKD

Based on the financial report for Jun 30, 2024, Beijing Tong Ren Tang Chinese Medicine Co Ltd's Total Equity amounts to 3.8B HKD.

What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's Total Equity growth rate?
Total Equity CAGR 10Y
11%

Over the last year, the Total Equity growth was 6%. The average annual Total Equity growth rates for Beijing Tong Ren Tang Chinese Medicine Co Ltd have been 7% over the past three years , 4% over the past five years , and 11% over the past ten years .

Back to Top